Cargando…
In Reply
This letter to the editor remarks on additional considerations for the management of febrile neutropenia during the COVID‐19 pandemic, in response to the letter by Boutayeb et al.
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267302/ https://www.ncbi.nlm.nih.gov/pubmed/32378772 http://dx.doi.org/10.1634/theoncologist.2020-0329 |
_version_ | 1783541439304564736 |
---|---|
author | Coomes, Eric A. Al‐Shamsi, Humaid O. Meyers, Brandon M. Alhazzani, Waleed Alhuraiji, Ahmad Chemaly, Roy F. Almuhanna, Meshari Wolff, Robert A. Ibrahim, Nuhad K. Chua, Melvin L.K. Hotte, Sebastien J. Elfiki, Tarek Curigliano, Giuseppe Eng, Cathy Grothey, Axel Xie, Conghua |
author_facet | Coomes, Eric A. Al‐Shamsi, Humaid O. Meyers, Brandon M. Alhazzani, Waleed Alhuraiji, Ahmad Chemaly, Roy F. Almuhanna, Meshari Wolff, Robert A. Ibrahim, Nuhad K. Chua, Melvin L.K. Hotte, Sebastien J. Elfiki, Tarek Curigliano, Giuseppe Eng, Cathy Grothey, Axel Xie, Conghua |
author_sort | Coomes, Eric A. |
collection | PubMed |
description | This letter to the editor remarks on additional considerations for the management of febrile neutropenia during the COVID‐19 pandemic, in response to the letter by Boutayeb et al. |
format | Online Article Text |
id | pubmed-7267302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72673022020-06-03 In Reply Coomes, Eric A. Al‐Shamsi, Humaid O. Meyers, Brandon M. Alhazzani, Waleed Alhuraiji, Ahmad Chemaly, Roy F. Almuhanna, Meshari Wolff, Robert A. Ibrahim, Nuhad K. Chua, Melvin L.K. Hotte, Sebastien J. Elfiki, Tarek Curigliano, Giuseppe Eng, Cathy Grothey, Axel Xie, Conghua Oncologist Letters to the Editor This letter to the editor remarks on additional considerations for the management of febrile neutropenia during the COVID‐19 pandemic, in response to the letter by Boutayeb et al. John Wiley & Sons, Inc. 2020-05-27 2020-08 /pmc/articles/PMC7267302/ /pubmed/32378772 http://dx.doi.org/10.1634/theoncologist.2020-0329 Text en © AlphaMed Press 2020 |
spellingShingle | Letters to the Editor Coomes, Eric A. Al‐Shamsi, Humaid O. Meyers, Brandon M. Alhazzani, Waleed Alhuraiji, Ahmad Chemaly, Roy F. Almuhanna, Meshari Wolff, Robert A. Ibrahim, Nuhad K. Chua, Melvin L.K. Hotte, Sebastien J. Elfiki, Tarek Curigliano, Giuseppe Eng, Cathy Grothey, Axel Xie, Conghua In Reply |
title | In Reply |
title_full | In Reply |
title_fullStr | In Reply |
title_full_unstemmed | In Reply |
title_short | In Reply |
title_sort | in reply |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267302/ https://www.ncbi.nlm.nih.gov/pubmed/32378772 http://dx.doi.org/10.1634/theoncologist.2020-0329 |
work_keys_str_mv | AT coomeserica inreply AT alshamsihumaido inreply AT meyersbrandonm inreply AT alhazzaniwaleed inreply AT alhuraijiahmad inreply AT chemalyroyf inreply AT almuhannameshari inreply AT wolffroberta inreply AT ibrahimnuhadk inreply AT chuamelvinlk inreply AT hottesebastienj inreply AT elfikitarek inreply AT curiglianogiuseppe inreply AT engcathy inreply AT grotheyaxel inreply AT xieconghua inreply |